Beta-(1,3/1,6)-D-glucan Helps to Decrease Opportunistic Infections in Crohn's Disease Patients Treated with Biological Therapy
<p><strong>Background:</strong> Secondary intercurrent infections in patients with inflammatory bowel disease (IBD) represent a very important problem in daily clinical practice because of their significant contribution to quality of life and work ability. Beta-glucans are known to...
Saved in:
Main Authors: | Batovsky Marian (Author), Zamborsky Tomas (Author), Radwan Khaled (Author), Desatova Barbora (Author), Kadleckova Barbora (Author) |
---|---|
Format: | Book |
Published: |
Archives of Clinical Gastroenterology - Peertechz Publications,
2015-06-26.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-Glucan in Foods and Health Benefits
Published: (2022) -
Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn's Disease
by: Yanmin Guo, et al.
Published: (2015) -
Nutraceutical functions of beta-glucans in human nutrition
by: Anna Ciecierska, et al.
Published: (2019) -
Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study
by: Zuzana Rennerova, et al.
Published: (2022) -
Functional activities of beta-glucans in the prevention or treatment of cervical cancer
by: Shahla Chaichian, et al.
Published: (2020)